Animal Nursing I Test One Review
Core Veterinary Medical Abbreviations
Patient Demeanor and Scheduling Abbreviations:
QAR: Quiet, alert, responsive.s.i.d./u.i.d./q24hrs: Once daily.t.i.d.: Three times daily.q.i.d.: Four times daily.q.d.: Every day.q.o.d.: Every other day.Caps: Capsules.No reps: No repeats (no refills on prescriptions).Ad lib: Without restricting amount (freely, as in ad libitum feeding).Prn: As required / as needed.
Anatomical, Clinical, and Charting Notation:
O.D.: Right eye (oculus dexter).O.S.: Left eye (oculus sinister).ō: Owner.ñ: Normal.NAF: No abnormal findings.NPL: No palpable lesions.Bx: Biopsy.Dx: Diagnosis.Rx: Prescription.
Patient History and Physical Examination
Components of a Comprehensive Medical History:
- History of Present Illness (HPI): Detailed timeline and character of the active clinical complaint.
- Past Medical and Surgical History: Prior illnesses, surgical interventions, anesthetic reactions, and hospitalizations.
- Environmental History: Indoor/outdoor status, travel history, housing arrangements, exposure to toxins, and contact with other animals or wildlife.
- Medication History: Current prescriptions, non-prescription remedies, dosages, frequency, and preventatives.
- Dietary History: Brand, formulation, feeding frequency, treats, human food exposure, and recent diet changes.
- Systems Review: Systematic inquiry querying each organ system with one to two open-ended questions to elicit clinical abnormalities without leading the client.
Systems of the Physical Examination:
- A complete evaluation requires physical inspection across all primary body systems:
- Skin and coat (integumentary system).
- Eyes, ears, and nares.
- Gastrointestinal system.
- Respiratory system.
- Musculoskeletal system.
- Cardiovascular system.
- Reproductive and urinary (urogenital) systems.
- Lymphatic system.
- Neurological system.
Signalment and Problem-Oriented Medical Records (POMR)
Signalment Components:
- Age: Exact or estimated age of the patient.
- Species: Canine, feline, avian, reptile, etc.
- Breed: Purebred or specific mixed breed.
- Gender: Male or female.
- Reproductive Status: Intact, spayed (ovariohysterectomy), or neutered/castrated.
Structure of the Problem-Oriented Medical Record (POMR):
- Data:
- Chief complaint.
- Patient signalment.
- Detailed patient medical history.
- Physical examination baseline findings.
- Diagnostic laboratory and imaging test results.
- Problems:
- Clinical abnormalities.
- Abnormal physical examination findings.
- Laboratory abnormalities.
- Verified disease status.
- Plans:
- Diagnostic plans (further tests, imaging, cytology).
- Therapeutic plans (medications, fluid therapy, dietary interventions).
- Client education initiatives documented directly in the record.
- Progress Notes (SOAP Format):
- S (Subjective): Observations regarding how the patient appears, behavior, demeanor, appetite, and non-quantifiable signs.
- O (Objective): Quantifiable data and hard numbers, including temperature, pulse/heart rate, respiratory rate, blood pressure, laboratory values, fluid output, and weight.
- A (Assessment): Clinical interpretation combining subjective and objective data; evaluating patient progress, response to therapy, or differential diagnoses.
- P (Plan): Actionable medical interventions to execute next, adjustments to therapies, or diagnostic tests to order.
The Eight Basic Needs of Hospitalized Animals
1. Relief from Pain:
- Relieving pain and suffering is a legally mandated clinical duty of veterinary care providers.
2. Adequate Respiration:
- The animal must be maintained such that tissues receive sufficient oxygen () delivery and carbon dioxide () is effectively eliminated from the body.
3. Appropriate Comfortable Environment:
- Nursing attitude and the quality of housing provided dramatically influence patient recovery.
4. Adequate Levels of Rest and Activity:
- Deprivation of sleep and physical rest impairs tissue healing; physical activity must be calibrated directly to the animal's underlying medical condition.
5. Adequate Nutrition:
- Inappetence and hyporexia serve as primary early indicators of underlying systemic pathology and must be identified and corrected immediately.
6. Proper Excretion of Wastes:
- Systematic clinical monitoring of waste output is mandatory; abnormalities in color, frequency, volume, and odor must be documented.
7. Social Interaction with Caregivers and Owners:
- Psychological and behavioral needs require regular intervention alongside physical treatments.
8. Adequate Fluids and Electrolytes:
- Hydration and electrolyte levels must be sustained to meet metabolic demands, replace active losses, and prevent systemic dehydration.
Clinical Assessment and Management of Pain
Clinical Signs of Pain:
- Vocal and Behavioral Signs: Vocalization (whining, groaning, howling), abnormal or rigid posturing, frequent position changes, reluctance or unwillingness to move, restlessness, severe depression, inappetence, trembling.
- Physiological Indicators: Elevated heart rate (tachycardia), increased respiratory rate (tachypnea), elevated blood pressure (hypertension), elevated body temperature (hyperthermia), poor mucous membrane quality.
- Focal Physical Responses: Licking, chewing, guarding, flinching upon palpation, and fixed staring at the painful anatomical site.
Targeting Interventions Along the Pain Pathway:
- Peripheral Receptor Site: Remove the inciting cause and halt further noxious stimuli locally.
- Peripheral Nerve Transmission: Prevent impulse conduction from peripheral nerve terminals to the spinal cord using local anesthetics.
- Spinal Level Transmission (Modulation): Block nociceptive signals centrally at the spinal dorsal horn via epidural anesthesia or pharmacological agents like ketamine.
- Central Perception Alteration: Attenuate brain processing of pain centrally using opioids and gabapentin.
- Central Psychological Modulation: Alleviate the affective component of pain via psychological interventions and tender loving care (TLC) visits.
Analgesic Treatment Modalities:
- Pre-emptive Analgesia: Administration of analgesics prior to the onset of tissue trauma and noxious surgical stimulus.
- Pharmacological Agents: Nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, alpha-2 adrenergic agonists, local blocks, epidural blocks, and adjunctive agents.
- Non-Pharmacological Therapies: Tender loving care (TLC), consistent human contact, therapeutic massage, clinical acupuncture, and provision of favorite toys.
Clinical Assessment and Management of Dyspnea
Clinical Signs of Dyspnea:
- Open-mouth breathing (especially critical in felines).
- Auditory abnormalities: wheezing, coughing, stridor, or stertor.
- Labored, exaggerated, or paradoxical respiratory effort.
- Marked tachypnea.
- Orthopnea and reluctance to adopt a sternal or lateral recumbent position.
- Cyanosis characterized by muddy, bluish mucous membranes.
Etiologies of Dyspnea:
- Upper or lower airway obstructions.
- Reduced functional lung parenchymal volume (pneumonia, contusions, edema).
- Hydrothorax / pleural effusion.
- Pneumothorax.
- Advanced kidney disease (uremic pneumonitis, metabolic acidosis compensation).
- Congenital vascular shunts.
Emergency Dyspnea Management:
- Administer oxygen therapy immediately: unless the patient or the clinic is actively on fire, provide oxygen.
Comfort, Hygiene, and Socialization in Hospitalized Patients
Causes of Inpatient Discomfort:
- Inappropriate ambient room temperature and relative humidity.
- Insufficient, damp, or inappropriate bedding substrate.
- Soiled cages, urine scald, or fecal contamination.
- Restricted or absent access to elimination facilities.
- Ectoparasitic infestations.
- Inadequate enclosure dimensions.
- Bandages, splints, casts, or slings that are improperly applied, constrictive, or slipping.
Interventions to Maximize Patient Comfort:
- Clean soiled kennels immediately upon voiding.
- Maintain patient skin completely clean and dry.
- Provide continuous access to an elimination area or frequent walks.
- Calibrate room temperature to the target species; supply external warming modalities when clinically indicated.
- Select appropriately sized enclosures to permit normal movement.
- Provide abundant clean, dry bedding.
- Eliminate ectoparasites.
- Incorporate familiar bedding, clothing, or items brought from the owner's home.
- Maintain quiet surroundings and manage clinical noise levels.
Hospital Socialization Strategies:
- Grooming and brushing.
- Petting, gentle handling, and talking.
- Scheduled owner visits.
- Introduction of environmental toys.
- Structured exercise periods.
- Positive staff interactions unassociated with clinical treatments or painful interventions.
- Supervised contact with conspecifics when medically permissible and behaviorally tolerated.
Gastrointestinal, Nutritional, and Elimination Management
Etiologies of Inappetence:
- Severe systemic disease.
- Generalized muscle weakness and malaise.
- Oral cavity, pharyngeal, or esophageal disorders.
- Unmanaged somatic or visceral pain.
- Environmental stress and fear.
- Febrile states.
Stepwise Protocol for Managing Inappetence:
- Step 1 (Appetite Stimulation / Voluntary Ingestion): Encourage spontaneous eating by warming the food to enhance aroma, sitting quietly with the patient, switching between feeding from a plate versus a bowl, or smearing small amounts of food directly onto paws or lips.
- Step 2 (Assisted Feeding): Manually place a bolus of food directly into the caudal oral cavity.
- Step 3 (Enteral Tube Feeding): Institute tube feeding (nasoesophageal, nasogastric, esophagostomy, or gastrostomy routes) when voluntary and assisted techniques fail.
Urinary System Pathologies:
- Causes of Urinary Dysfunction: Mechanical obstruction of the urinary tract (urethral plugs, calculi), ruptured urinary bladder, chronic or acute kidney disease, liver disease, inadequate neurological bladder innervation, and absence of suitable elimination facilities.
Fecal Elimination Pathologies:
- Causes of Constipation: Megacolon, nerve injury (sacral/pelvic plexus damage), physical intraluminal blockages, healed or displaced pelvic fractures, inappropriate dietary composition, deficient water consumption, insufficient dietary fiber intake, and physical inactivity/lack of exercise.
- Causes of Diarrhea: Viral infections, primary or opportunistic bacterial enteritis, endoparasitic infestation, and dietary allergies/intolerances.
- Dyschezia (Difficulty Defecating): Structural rectal diseases, anal sac or perianal disease, and orthopedic or vertebral back pain.
Classification of Disease: Definitions and the DAMNIT Scheme
Foundational Pathological Terminology:
- Disease: Any abnormal condition of the body that impairs normal physiological function.
- Pathology: The scientific study of disease, its underlying causes, structural/functional changes, and clinical progression.
- Etiology: The specific causative agent or root cause of a disease process (e.g., bacteria, viruses, toxicoses).
- Lesion: A structural or functional tissue abnormality, observable at either a gross or microscopic level.
- Zoonosis: An infectious disease transmissible under natural conditions from vertebrate animals to humans.
- Peracute Disease: Disease state characterized by a sudden onset and exceptionally rapid progression; resulting in death or complete clinical recovery within several hours.
- Acute Disease: Disease characterized by rapid clinical onset with a course running several days; commonly necessitates patient hospitalization.
- Subacute Disease: Clinical state intermediate between acute and chronic duration; patient often appears clinically well, with disease discovered primarily via diagnostic testing.
- Chronic Disease: Pathological condition demonstrating a slow, insidious onset, gradual progression, and long duration; predominantly managed on an outpatient basis.
The DAMNIT Diagnostic Classification Scheme:
- D – Developmental / Degenerative:
- Developmental Diseases: Conditions present at birth or emerging during developmental maturation.
- Genetic causes (e.g., dilated cardiomyopathy in Doberman Pinschers).
- In utero toxin exposure (e.g., cyclopia in lambs whose dams ingested teratogenic veratrum plants).
- Transplacental infectious transmission (e.g., cerebellar hypoplasia in kittens whose dam was infected with feline panleukopenia virus during gestation).
- Idiopathic intrauterine disturbances (e.g., cleft palate, congenital umbilical hernia).
- Degenerative Diseases: Chronic, progressive wear-and-tear conditions; inherently refractory to cures; managed to provide analgesia and preserve baseline function.
- Examples: Lens cataracts, canine hip dysplasia, sensory hearing loss, degenerative joint disease/osteoarthritis, congestive heart failure.
- A – Autoimmune:
- Pathophysiology in which the adaptive immune system produces antibodies or sensitized T lymphocytes directed against self-antigens.
- Management: Pharmacological immunosuppression (e.g., systemic corticosteroid therapy such as prednisone).
- Examples: Systemic lupus erythematosus (SLE), pemphigus complex diseases, immune-mediated hemolytic anemia (IMHA).
- M – Metabolic / Multifactorial:
- Metabolic Diseases: Endocrine or hormonal dysfunctions caused by hypersecretion or hyposecretion of biochemical messengers resulting in metabolic derangement; diagnosed via serum chemistry and endocrine testing panels.
- Examples: Diabetes mellitus, Cushing's disease (hyperadrenocorticism), Addison's disease (hypoadrenocorticism), hypothyroidism, hyperthyroidism.
- Multifactorial Diseases: Syndromes stemming from complex interactions of multiple distinct etiologies.
- Examples: Feline Lower Urinary Tract Disease (FLUTD), canine otitis externa, shipping fever complex in bovine herds, canine hip dysplasia.
- N – Nutritional / Neoplastic:
- Nutritional Diseases: Resulting from overfeeding, starvation/underfeeding, or unbalanced nutritional ratios.
- Examples: Gastric dilatation-volvulus (bloat), feline dilated cardiomyopathy induced by dietary taurine deficiency, nutritional secondary osteodystrophy / metabolic bone disease in green iguanas fed calcium-deficient diets.
- Neoplastic Diseases: Uncontrolled, abnormal cellular proliferation forming benign or malignant tumors.
- Breed predispositions: Hemangiosarcoma in Bernese Mountain Dogs.
- Mammary tumor malignancy statistics: Exactly of canine mammary neoplasms are malignant; exactly of feline mammary tumors are malignant.
- I – Immunological / Infectious / Iatrogenic:
- Immunological Diseases: Manifest as hyperactive immune responses (allergic reactions, flea allergy dermatitis, type I anaphylaxis treated via immunosuppression/antihistamines) or hypoactive immune deficiencies (inability to clear pathogens, FIV, FeLV treated with immunostimulants and prophylactic therapies).
- Infectious Diseases: Pathologies induced by biological pathogens; variable expression ranging from mild carrier states to fulminant lethality; preventable through immunization and treated with antimicrobial pharmaceuticals.
- Viral examples: Parvovirus, Feline Leukemia Virus, Rabies.
- Bacterial examples: Bovine mastitis, feline bite abscesses.
- Fungal examples: Dermatophytosis (ringworm), blastomycosis.
- Parasitic examples: Dirofilaria immitis (heartworm disease).
- Iatrogenic Diseases: Complications unintentionally induced by clinical medical management, surgical intervention, or human error.
- Examples: Severe perivascular necrosis and tissue sloughing from extravasated intravenous barbiturate injections, thermal burns secondary to unmonitored supplemental heating pads, adverse drug reactions.
- T – Toxicoses / Traumatic:
- Toxicoses: Pathological disruptions caused by deliberate or accidental ingestion or absorption of poisonous agents, running acute or chronic courses. Clinical signs include tremors, seizures, acute vomiting, profuse diarrhea, hemorrhage, and multi-organ failure.
- Implicated agents: Organophosphates (agricultural sprays, topical fly treatments), commercial chemical fertilizers, warfarin and anticoagulant rodenticides, toxic botanical plants, ethylene glycol (automotive antifreeze), strychnine, human prescription pharmaceuticals, and over-the-counter (OTC) medications.
- Traumatic Diseases: Physical injuries caused by motor vehicular impact, human interaction, conspecific/interspecific animal fights, or self-inflicted mutilation. Patients present with shock, internal hemorrhage, and severe pain requiring intensive life support; multi-organ trauma is common beneath intact skin.
- Examples: Hit By Car (HBC), feline bite abscesses, acral lick granulomas, dog fight wounds (e.g., Big Dog Little Dog / BDLD incidents).
- Additional Disease Classifications:
- Environmental Diseases: Pathologies directly induced by thermal extremes (heatstroke, hypothermia), poor sanitation, shipping/transport stress, and high-density crowding.
- Unknown / Idiopathic Diseases: Syndromes lacking an established distinct etiology, such as feline hepatic lipidosis (fatty liver syndrome), which may stem from primary hepatic metabolic defects or secondary anorexia induced by environmental stressors.
Feline Infectious Diseases
Feline Viral Rhinotracheitis (FVR):
- Etiology: Feline Herpesvirus-1 (FHV-1). Together with Feline Calicivirus, it is responsible for of all infectious feline upper respiratory tract diseases.
- Epizootiology: Highly contagious; common in juvenile, unimmunized cats within crowded shelter or cattery settings. Persists as a lifelong latent carrier state with intermittent shedding.
- Transmission: Direct contact with infected oral, ocular, or nasal secretions, aerosolized coughing droplets, and shared fomites.
- Clinical Presentation: Spiking fever, marked depression, sneezing, coughing, conjunctivitis, dendritic corneal/eye ulcers, serous-to-mucopurulent ocular and nasal discharge, excessive salivation (ptyalism), and severe inappetence.
- Prevention and Treatment: Included within core FVRCP vaccination formulations (parenteral injectable and intranasal options; reduces severity but is not protective). Treatment is entirely supportive (fluid therapy, warm humidification, nutritional maintenance).
Feline Calicivirus (FCV):
- Etiology and Presentation: Single-stranded RNA calicivirus often co-infecting alongside FVR; produces a typically milder clinical respiratory syndrome but is marked by characteristic ulcerative stomatitis.
- Pathognomonic Lesions: Prominent painful ulcerations of the oral mucosa, hard palate, dorsal tongue surface, and external nares.
- Clinical Signs: Oral ulcers induce extreme pain when eating, precipitating profound anorexia and dehydration.
- Management Protocol: Core FVRCP vaccination; supportive care utilizing subcutaneous (SQ) or intravenous (IV) fluid therapy, high-palatability/strong-smelling canned foods, assisted/force feeding, routine debridement of dried ocular/nasal exudate, and systemic broad-spectrum antibiotics to control secondary bacterial opportunistic infections.
Feline Chlamydiosis:
- Etiology: Intracellular bacterium Chlamydia psittaci (Chlamydophila felis).
- Clinical Presentation: Marked, persistent chemosis and conjunctivitis, with mild upper respiratory signs.
- Zoonotic Potential: Zoonotic; documented cause of follicular conjunctivitis in humans.
- Therapeutic Protocol: Highly responsive to targeted antibiotic therapy (e.g., systemic and topical tetracyclines/doxycycline). Because clinical manifestation is typically mild and responsive, it is designated as a non-core vaccine.
Feline Panleukopenia (Feline Distemper):
- Etiology: Feline Parvovirus (FPV). Extremely durable in the environment.
- Host Predisposition: Young, unvaccinated, and immunocompromised felines.
- Pathology and Clinical Signs: Rapid destruction of rapidly dividing cells (intestinal crypt epithelium and bone marrow stem cells). Signs: intractable vomiting, foul/watery diarrhea, profound dehydration, anorexia, leukopenia, endotoxic shock, and acute death. In utero transmission to pregnant queens causes fetal death, abortion, or neonatal cerebellar hypoplasia via destruction of the developing fetal external germinal layer.
- Management and Prevention: Routine immunization via core vaccine schedules provides robust protection and has dramatically minimized disease incidence. Inpatient therapy requires strict isolation protocols, aggressive IV crystalloid fluid resuscitation, broad-spectrum parenteral antibiotics to halt enteric bacteremia, and aggressive nutritional support.
Feline Leukemia Virus (FeLV):
- Etiology and Epizootiology: Retrovirus (γ-retrovirus) spread through persistent "friendly" close contact (mutual grooming, shared food/water receptacles, shared litter pans). Excreted in high titers within saliva, urine, and feces.
- Pathological Manifestations: Induces profound chronic immunosuppression leading to opportunistic secondary infections, development of lymphosarcoma (thymic, alimentary, multicentric), non-regenerative anemia, myelosuppression/bone marrow hypoplasia, spontaneous abortion, chronic rhinitis, and intractable periodontal disease.
- Diagnostic Testing and Prognosis: Evaluated using point-of-care enzyme-linked immunosorbent assay (ELISA) screening for free viral p27 antigen. Poor prognosis: exactly of persistently viremic cats succumb within of initial infection.
- Clinical Management: Non-core vaccine available for at-risk cohorts. Asymptomatic retroviral-positive patients benefit from aggressive preventive healthcare, rapid treatment of secondary infections, and strict segregation; FeLV-positive cats must be housed singularly without contact with retroviral-negative individuals.
Feline Immunodeficiency Virus (FIV):
- Etiology and Epizootiology: Lentivirus frequently designated as "feline AIDS." Transmission occurs almost exclusively via direct inoculation through deep penetrating cat bite wounds during aggressive territorial altercations; transmission via non-aggressive casual contact is uncommon.
- Clinical Pathophysiology: Progressive decline in cell-mediated immunity with depletion of CD4+ T lymphocytes. Clinical presentation involves chronic ulcerative gingivostomatitis, intractable chronic diarrhea, recurring fever of unknown origin, persistent conjunctivitis, generalized dermatitis, and refractory wasting.
- Vaccination and Quarantine Protocols: A non-core vaccine was historically developed, but is considered questionable and not broadly recommended due to efficacy concerns and diagnostic interference (vaccinated individuals produce antibodies that cause standard ELISA screening assays to test positive). Positive felines require solitary indoor housing to eliminate conspecific fighting and disease propagation.
Feline Infectious Peritonitis (FIP):
- Etiology: Induced by an in vivo virulent mutation of common, low-pathogenicity Feline Enteric Coronavirus (FECV). It is distinct from COVID-19 (SARS-CoV-2). While coronavirus exposure is widespread in feline populations, the specific de novo mutation into virulent FIP occurs in a small percentage of infected individuals.
- Forms and Clinical Manifestations:
- Effusive ("Wet") Form (Most Prevalent): Characterized by immune-complex vasculitis causing leakage of high-protein, straw-colored exudate into body cavities. Results in marked abdominal distension (ascites) or pleural effusion, waxing and waning pyrexia, anorexia, progressive cachexia/weight loss, non-regenerative anemia, and jaundice/icterus.
- Non-Effusive ("Dry") Form: Characterized by pyogranulomatous lesions and localized inflammatory granulomas seeded along parenchymal organs (kidneys, mesenteric lymph nodes, central nervous system, uveal tract of the eye). Signs are non-specific and insidious.
- Diagnosis, Prognosis, and Therapeutics: Extremely challenging antemortem diagnostic confirmation. Untreated cases carry an extremely poor prognosis, typically terminating in death within days to weeks of definitive onset. Modern emerging antiviral therapies (e.g., nucleoside analogs) demonstrate high clinical efficacy. An intranasal vaccine exists but is not recommended.
Canine Infectious Diseases and Zoonotic Pathogens
Rabies (Canine, Feline, and Mammalian Hosts):
- Pathogen Biology: Rhabdovirus affecting all homeothermic (warm-blooded) animals; classified as a classic zoonosis possessing an absolute fatality rate following the manifestation of overt clinical signs.
- Epizootiological Vector Reservoir: Transmission occurs primarily via inoculation of infected saliva through bite wounds from wild mammalian reservoir species (bats, raccoons, skunks, foxes).
- Clinical Signs: Variable neurotropic progression comprising behavior modifications (docile or placid individuals becoming violently aggressive, loss of innate fear of humans), progressive ascending lower motor neuron muscular paralysis, profuse salivation and inability to swallow saliva (hydrophobia), and severe ataxia/gait changes.
- Legal Mandates and Definitive Diagnostics: Mandatory vaccination of domestic canines and felines enforced by statutory law, supported by booster regimens. There is no curative treatment. Definitive diagnosis cannot be established antemortem; it is achieved exclusively post-mortem via direct immunofluorescence analysis of fresh brain tissue (specifically cross-sections of the cerebellum, hippocampus, and brainstem).
Canine Infectious Respiratory Disease Complex / Kennel Cough:
- Etiology: Synergistic polymicrobial infection driven by viral pathogens (Canine Parainfluenza Virus, Canine Adenovirus Type 2) combined with Bordetella bronchiseptica bacteria.
- Anamnesis and Signs: Consistent history of recent exposure to congregate canine environments (boarding kennels, daycares, animal shelters, dog parks, grooming facilities). Manifests as a sudden-onset, harsh, high-pitched, dry, non-productive "goose-honk" cough, easily elicited on tracheal palpation.
- Therapy and Immunization: Outpatient supportive management tailored to severity (cough suppressants, systemic antibiotics if secondary bacterial bronchopneumonia is suspected); high rate of spontaneous uncomplicated clinical recovery. Preventative vaccination (delivered via parenteral SQ, intranasal, or oral routes) is routinely mandated for boarding admittance.
Canine Distemper:
- Etiology and Spread: Highly contagious morbillivirus belonging to the Paramyxovirus family. Transmitted by direct dog-to-dog aerosol contact, exposure to infected secretions (respiratory droplets, urine), and contact with infected wild carnivores (raccoons, foxes, skunks).
- Target Population: Primarily young, unvaccinated puppies lacking maternal antibody protection, with histories of multi-dog exposure.
- Sequential Clinical Stages: Early presentation involves gastrointestinal signs (vomiting, diarrhea), severe mucopurulent oculonasal discharge, and epistaxis. Disease frequently progresses to systemic central nervous system invasion manifesting as generalized seizures, ataxia, and characteristic permanent focal muscle twitching (myoclonus / "chewing gum" focal tremors). Recovery rates drop dramatically following neurologic involvement; survivors typically retain permanent neurologic focal deficits.
- Therapeutic Protocol: Purely symptomatic inpatient supportive nursing care; preventative immunization within standard core vaccination series is highly effective.
Canine Parvovirus (CPV):
- Pathophysiological Profile: Non-enveloped parvovirus possessing extreme environmental stability and high morbidity and mortality. Demonstrates distinct breed sensitivities with elevated susceptibility to severe clinical collapse in Doberman Pinschers and Rottweilers.
- Target Age Cohort: Classical presentation occurs in puppies around of age, coinciding precisely with the window of vulnerability where protective maternally derived antibodies (MDA) wane before the puppy's primary vaccine series produces protective active immunity. Concurrent endoparasitism or coronavirus infections accelerate clinical decline.
- Transmission Dynamics and Signs: Transmission occurs via the fecal-oral route through direct contact or fomites. Pathogen targets and lyses rapidly dividing cells of the crypts of Lieberkõhn within the small intestine and bone marrow precursors. Signs: persistent vomiting, profound anorexia, severe mental depression, rapid hypovolemic/septic shock, and profuse, foul-smelling, bloody diarrhea caused by sloughing of the intestinal mucosal lining, accompanied by a pathognomonic odor.
- Inpatient Management: Strict barrier isolation, aggressive intravenous crystalloid and colloid fluid resuscitation, broad-spectrum IV antimicrobials to prevent sepsis, antiemetics, antiviral adjunctive therapies, and comprehensive nursing support.
Canine Coronavirus:
- Pathology: Produces a clinical enteritis resembling parvoviral infection, but significantly milder in virulence and clinical course. If an animal experiences concurrent infection with both coronavirus and parvovirus, mortality increases markedly.
- Target Population and Management: Typically affects young puppies. Managed strictly through outpatient/inpatient isolation and supportive symptomatic care. Vaccination is not considered a routine core protocol.
Leptospirosis:
- Etiology and Transmission: Spirochete bacteria (Leptospira interrogans sensu lato). A critical zoonotic pathogen affecting domestic canines of any age, breed, or lifestyle. Transmitted via mucosal or abraded cutaneous exposure to water, soil, or food contaminated with urine from infected wildlife hosts (rodents, raccoons, deer).
- Clinical Presentation: Acute lethargy, pyrexia, generalized muscle and abdominal pain, acute vomiting, anorexia, profound polydipsia, and rapid onset of acute renal failure coupled with hepatic insufficiency manifesting as icterus/jaundice.
- Biosecurity and Clinical Protocol: Veterinary personnel must don full personal protective equipment (PPE), with mandatory barrier gloves when handling urine or cleaning cages of dogs presenting with acute unexplained renal failure or icterus. Aggressive treatment utilizing IV fluids, targeted antibiotic therapy (intravenous penicillins/ampicillin followed by oral doxycycline to completely clear renal tubular carriage and eliminate the shedding carrier state), and organ support. Polyvalent bacterin vaccines provide protection, though they may not cross-protect against emergent wild field serovars.
Canine Influenza Virus (CIV):
- Viral Characteristics: Highly contagious orthomyxovirus (subtypes H3N8 and H3N2) causing respiratory illness in canines and capable of infecting felines. Spreads efficiently via aerosolized respiratory droplets generated through coughing, barking, or sneezing, as well as fomites. Survives on dry environmental surfaces for up to .
- Epizootiology: High attack rates within high-density animal boarding facilities, daycares, and sheltering systems.
- Immunization Considerations: Lifestyle-based vaccination is strongly recommended for canines entering high-risk social settings; immunization significantly reduces overall viral shedding, clinical symptom severity, and pneumonia risk.
Vector-Borne Diseases: Lyme Disease and Heartworm Disease
Lyme Disease (Borreliosis):
- Etiology and Transmission: Spirochete Borrelia burgdorferi, transmitted through the bite of the black-legged deer tick (Ixodes scapularis). Infection requires an attachment and blood-feeding period of for the spirochete to migrate from the tick's midgut to its salivary glands and enter the vertebrate host.
- Zoonotic Status: Both canines and humans are susceptible to infection; however, Lyme disease is not a direct zoonosis (it cannot be transmitted directly from a dog to a human; infection requires the tick vector).
- Therapeutic and Prevention Strategies: Treated via prolonged, long-term antibiotic administration (e.g., minimum 30-day course of oral doxycycline). Prevention requires consistent year-round acaricide/tick preventative applications, prompt manual tick extraction, and vaccination in endemic geographic regions.
Heartworm Disease (Dirofilariasis):
- Etiological Agent and Vector: Nematode Dirofilaria immitis, biologically vectored and transmitted via mosquitoes.
- Canine Pathophysiology and Clinical Signs: Adult nematodes reside in the pulmonary arteries and right ventricle of the heart. Chronic infection leads to pulmonary hypertension, vascular endothelial damage, coughing, exercise intolerance, progressive weight loss, right-sided congestive heart failure, and abdominal ascites.
- Feline Heartworm Disease Variations: High biological susceptibility with atypical clinical presentation; infection by only induces life-threatening pathology (Heartworm-Associated Respiratory Disease / HARD). Dying or dead adult worms trigger pulmonary arterial thromboembolism, precipitating acute salivation, sudden vomiting, watery diarrhea, collapse, grand mal seizures, and acute hemoptysis (coughing up frank blood).
- Canine Adulticide Therapy Protocol: Requires a phased therapeutic approach designed to kill both circulating microfilariae and mature adult nematodes using deep intramuscular injections of adulticide (melarsomine dihydrochloride). Following adulticide therapy, strict cage confinement and exercise restriction are mandatory for ; fragmented, dead adult worms disintegrate and embolize into the pulmonary arterial tree, where physical exertion risks severe pulmonary thromboembolism, cardiovascular collapse, and death.
- Testing and Preventative Guidelines: Routine antigen and microfilarial testing should be executed annually. In compliant clients maintaining rigorous monthly chemoprophylaxis regimens, testing intervals may extend to every . The minimum required prophylactic window in temperate zones extends from May through October; year-round chemoprophylaxis is clinically preferred due to shifting global climate patterns. Dispensing or administering heartworm preventative medications without documented prior diagnostic testing is legally considered extra-label drug use, requiring an informed consent waiver signed by the owner. Recommendations regarding heartworm prophylaxis regimens are determined by geographical vector risk.